Companies Related to "Neural Substrates in Nicotine Withdrawal" [Most Relevant Company Matches] - Page: 5 [Advanced Search Results] RSS

05:56 EST 22nd February 2019 | BioPortfolio

Here are the most relevant search results for "Neural Substrates in Nicotine Withdrawal" found in our extensive corporate database of over 50,000 company records.

Showing "Neural Substrates Nicotine Withdrawal" Companies 101–108 of 108

Probably Relevant

Quality Controlled Biochemicals

Quality Controlled Biochemicals has over 10 years of experience as a full-service supplier of Custom Peptides and Custom Antibodies to scientists in academia and the bio-pharmaceutical industry. We have worked with researchers on the lipidation of peptides for use in vaccines or as drug delivery systems in intact cells. Our multi-phosphorylated peptides are used as reagents in protein phosphorylat...

Neuralstem, Inc.

Neuralstem's patented technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells into mature, physiologically relevant human neurons and glia. The company is targeting major central nervous system diseases includi...

Plastic Logic Limited

Plastic Logic is a leading developer of plastic electronics technology. It develops and exploits new manufacturing processes which combine the power of electronics with the pervasiveness of printing. The company's technology enables new product concepts in a wide range of markets including displays and sensors. The technology has the potential to radically change the economics of key segments of t...

Catalyst Pharmaceutical Partners

Catalyst is a specialty pharmaceutical company of Coral Gables, Florida, that acquires or in-licenses, develops and commercializes prescription drugs for the treatment of drug addiction. Catalyst is developing vigabatrin (designated CPP-109 by Catalyst) for the treatment of addiction to cocaine, methamphetamine and other addictive substances. The National Institute on Drug Abuse has stated that f...

Possibly Relevant

Inspiralis Limited

Inspiralis Limited is a company which supplies high-quality research products and services to both the pharmaceutical industry and academia. We specialise in supplying topoisomerases, including bacterial DNA gyrase, topo IV, human topo I and II, as well as their substrates, (supercoiled pBR322, relaxed pBR322 and kDNA). We also provide topoisomerase inhibitor screening assays (both low and high th...

Proneuron Biotechnologies (Israel) Limited

Proneuron Biotechnologies is developing therapies for neurological, ophthalmologic and immune-related disorders such as spinal cord injuries, multiple sclerosis, glaucoma, Parkinson's disease and Alzheimer's diseases. The technology derives from research on key mechanisms in the dialogue between the nervous and immune systems originating from The Weizmann Institute of Science. Proneuron's novel st...

BioRobotics Limited

BioRobotics was founded as a privately funded venture with the aim of providing quality solutions to automation and robotics in the field of molecular biology. The BioPick, the company’s first product, is used for the generation of genomic libraries. Capable of picking randomly grown colonies of yeast, Escherichia coli or phage into 96 or 384 well microtitre plates, the instrument runs unattende...

Full Moon BioSystems, Inc

Full Moon BioSystems, Inc. is one of the foremost companies in the biotechnology industry. We focus on accelerating, simplifying and improving drug discovery with innovative technologies and products. We supply to the top biotech companies and universities around the world.Full Moon BioSystems developed several key proprietary technologies. In particular, its unique polymer coating technology p...

More From BioPortfolio on "Neural Substrates in Nicotine Withdrawal"

Quick Search


Corporate Database Quicklinks